‘Macro overshadowing micro’: Capitalmind AMC expects selling despite decent Q2 results
CNBC-TV18 56 min ago·5 Oct 2026, 7:54 am
Anoop Vijaykumar of Capitalmind AMC suggests that broader market selling pressures may persist despite the recent improvement in corporate earnings. He argues that current macroeconomic factors are dominating investment decisions, overshadowing the positive performance of individual companies. This cautious outlook implies that while specific sectors might perform well, the overall market sentiment could remain volatile in the near term.
This perspective is particularly relevant for investors tracking large-cap IT and consumption stocks. Vijaykumar notes that while the pharma sector is expected to stay resilient, largecap IT and discretionary consumption sectors face headwinds. These sectors are particularly sensitive to interest rate changes, which investors are closely monitoring as central banks adjust their monetary policies to combat inflation.
Looking ahead, investors should keep a close watch on global interest rate trends and inflation data. The market's reaction to these macroeconomic indicators will likely dictate the direction of largecap stocks. Monitoring corporate earnings reports and policy statements from major central banks will be crucial for understanding the sustainability of the current market rally.
Excerpt from CNBC-TV18
Anoop Vijaykumar of Capitalmind AMC expects pharma to remain resilient but sees a slower recovery for largecap IT, while staying cautious on consumption stocks amid rate hike concerns. Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or…Read the original at CNBC-TV18
Key takeaways
- Category: Corporate Action.
- Flagged as a high-impact, market-moving story.
Why it matters
This is a high-impact development and could move the stock. Use the price and stock snapshot to gauge how the market is responding.
